Company: NCNA
Filing Date: 2025-03-20
Form Type: 20-F
Source: 0000950170-25-042709
Chunk: 192

Company: NuCana plc
Filing Date: 2025-03-20
Form: 20-F
Item: Item 6
Chunk 192
---
Item 6. Directors, Senior Management and Employees
 A. Directors and Senior Management
 The following table sets forth the names, ages and positions of our executive officers and directors as of March 1, 2025:
 

Name                          Age   Position                            
Executive Officers                                                      
Hugh Griffith                  56   Chief Executive Officer and Director
Jeffrey Bloss                  68   Chief Medical Officer               
David Harrison                 65   Head of Translational Studies       
Non-Executive Directors                                                 
Andrew Kay                     69   Non-Executive Director and Chairman 
Adam George (1)                55   Non-Executive Director              
Martin Mellish (2)             67   Non-Executive Director              
Cyrille Leperlier              71   Non-Executive Director              
Elliott Levy                   66   Non-Executive Director              
Bali Muralidhar                45   Non-Executive Director              
 (1)After the filing of this Annual Report, Mr. George intends to resign as the audit committee chair and as a director of the Company, effective March 21, 2025. Mr. George’s anticipated departure is not the result of any disagreement with us on any matter related to our operations, policies or procedures (financial reporting, accounting or otherwise).
 (2)Mr. Mellish intends to succeed Mr. George as audit committee chair upon Mr. George’s resignation, effective March 21, 2025.
 
Executive Officers
 Hugh Griffith is our co-founder and has served as our Chief Executive Officer and as a member of our board of directors since our operations began in March 2008. Mr. Griffith previously served as a non-executive director of MedAnnex Limited from 2010 to 2024, Thirty Holdings Limited from 2018 to 2023 and EdixoMed Limited from 2011 to 2023, when it was acquired by Convatec Group. Prior to founding NuCana, Mr. Griffith was Chief Operating Officer of Bioenvision, Inc., a biopharmaceutical company, from July 2004 until December 2007, when it was acquired by Genzyme Corporation (now Sanofi). He previously served as Commercial Director of Bioenvision, Inc. from September 2002 to June 2004. Before that, Mr. Griffith held several senior commercial positions at Quantanova Limited, a biopharmaceutical company, from January 2002 to July 2002, Abbot Laboratories (now AbbVie Inc.) from October 1995